Frozen section could spare rectal cancer patients from major surgery

NCT ID NCT07337811

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial is testing whether a quick lab test during surgery can help some people with low rectal cancer avoid a major operation. After radiation therapy, patients with a good response undergo a small local excision. If the frozen section shows no deep cancer, they skip the larger surgery and enter a watch-and-wait program. If cancer is deeper, they get immediate complete removal. The goal is to see if this selective approach keeps cancer under control while reducing complications and preserving quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Selective total mesorectal excision based on intra-operative frozen section
What this could lead to
If successful, this approach could allow many patients with low rectal cancer to avoid major surgery and a permanent colostomy, preserving bowel function and quality of life.
What could go wrong
This is a small, early-phase trial with only 27 participants, so results may not apply broadly. There is a risk that the frozen-section analysis may miss cancer cells, leading to undertreatment or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651

    RECRUITING

    Guangzhou, Guanggong, 510060, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.